Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1986 Feb;61(2):168–172. doi: 10.1136/adc.61.2.168

Antinuclear antibody studies in juvenile chronic arthritis.

A M Leak, B M Ansell, S J Burman
PMCID: PMC1777568  PMID: 3485405

Abstract

This study of children with chronic arthritis confirms that patients at greatest risk for chronic iridocyclitis have a young age of onset and positive antinuclear antibodies (ANA). Children who are ANA negative have a low risk of iridocyclitis. When it occurs it is at a significantly older age. No child developing juvenile chronic arthritis over 9, even with positive ANA, had chronic iritis. There was remarkable variation in ANA titres; these correlated with erythrocyte sedimentation rate, active arthritis, and iridocyclitis. Maximum ANA titres were often seen very early in the disease but at this time were usually not associated with a poor prognosis. Histocompatibility antigens A2 and DRw8 were significantly increased, suggesting primary associations in pauciarticular arthritis with ANA. HLA-DR5 was associated with mild forms of arthritis and with absence of, or only mild, iritis. HLA-B15/w62 was associated with severe forms of eye involvement.

Full text

PDF
172

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alspaugh M. A., Miller J. J. A study of specificities of antinuclear antibodies in juvenile rheumatoid arthritis. J Pediatr. 1977 Mar;90(3):391–395. doi: 10.1016/s0022-3476(77)80699-9. [DOI] [PubMed] [Google Scholar]
  2. Bluestone R., Goldberg L. S., Katz R. M., Marchesano J. M., Calabro J. J. Juvenile rheumatoid arthritis--a serologic survey of 200 consecutive patients. J Pediatr. 1970 Jul;77(1):98–102. doi: 10.1016/s0022-3476(70)80050-6. [DOI] [PubMed] [Google Scholar]
  3. Egeskjold E. M., Johansen A., Permin H., Høyeraal H. M., Sørensen T. The significance of antinuclear antibodies in juvenile rheumatoid arthritis associated with chronic bilateral iridocyclitis. Acta Paediatr Scand. 1982 Jul;71(4):615–620. doi: 10.1111/j.1651-2227.1982.tb09484.x. [DOI] [PubMed] [Google Scholar]
  4. Førre O., Dobloug J. H., Høyeraal H. M., Thorsby E. HLA antigens in juvenile arthritis. Genetic basis for the different subtypes. Arthritis Rheum. 1983 Jan;26(1):35–38. doi: 10.1002/art.1780260106. [DOI] [PubMed] [Google Scholar]
  5. Glass D., Litvin D., Wallace K., Chylack L., Garovoy M., Carpenter C. B., Schur P. H. Early-onset pauciarticular juvenile rheumatoid arthritis associated with human leukocyte antigen-DRw5, iritis, and antinuclear antibody. J Clin Invest. 1980 Sep;66(3):426–429. doi: 10.1172/JCI109872. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hoyeraal H. M. Granulocyte reactive antinuclear factors in juvenile rheumatoid arthritis. Scand J Rheumatol. 1976;5(2):84–90. doi: 10.3109/03009747609099896. [DOI] [PubMed] [Google Scholar]
  7. Kornreich H. K., Drexler E., Hanson V. Antinulear factors in childhood rheumatic diseases. J Pediatr. 1966 Dec;69(6):1039–1045. doi: 10.1016/s0022-3476(66)80293-7. [DOI] [PubMed] [Google Scholar]
  8. Miller M. L., Fraser P. A., Jackson J. M., Larson M. G., Petersen R. A., Chylack L. T., Jr, Glass D. N. Inherited predisposition to iridocyclitis with juvenile rheumatoid arthritis: selectivity among HLA-DR5 haplotypes. Proc Natl Acad Sci U S A. 1984 Jun;81(11):3539–3542. doi: 10.1073/pnas.81.11.3539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Permin H., Hørbov S., Wiik A., Knudsen J. V. Antinuclear antibodies in juvenile chronic arthritis. Acta Paediatr Scand. 1978 Mar;67(2):181–185. doi: 10.1111/j.1651-2227.1978.tb16300.x. [DOI] [PubMed] [Google Scholar]
  10. Petty R. E., Cassidy J. T., Sullivan D. B. Clinical correlates of antinuclear antibodies in juvenile rheumatoid arthritis. J Pediatr. 1973 Sep;83(3):386–389. doi: 10.1016/s0022-3476(73)80260-4. [DOI] [PubMed] [Google Scholar]
  11. Rossen R. D., Brewer E. J., Person D. A., Templeton J. W., Lidsky M. D. Circulating immune complexes and antinuclear antibodies in juvenile rheumatoid arthritis. Arthritis Rheum. 1977 Nov-Dec;20(8):1485–1490. doi: 10.1002/art.1780200807. [DOI] [PubMed] [Google Scholar]
  12. Rudnicki R. D., Ruderman M., Scull E., Goldenberg A., Rothfield N. Clinical features and serologic abnormalities in juvenile rheumatoid arthritis. Arthritis Rheum. 1974 Nov-Dec;17(6):1007–1015. doi: 10.1002/art.1780170613. [DOI] [PubMed] [Google Scholar]
  13. Schaller J. G., Johnson G. D., Holborow E. J., Ansell B. M., Smiley W. K. The association of antinuclear antibodies with the chronic iridocyclitis of juvenile rheumatoid arthritis (Still's disease). Arthritis Rheum. 1974 Jul-Aug;17(4):409–416. doi: 10.1002/art.1780170411. [DOI] [PubMed] [Google Scholar]
  14. Schaller J. G. Juvenile rheumatoid arthritis. Pediatr Ann. 1982 Apr;11(4):375–382. doi: 10.3928/0090-4481-19820401-08. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES